Riskpilot← Back to searchSign inGet full accessDyrlægegruppen Dania A/S
A/SActiveCVR 41072164Finlandsvej 1Veterinary activities · NACE 7500Est. 201930 employees
Revenue 2025
DKK 12,4M
-9% vs 2024
EBITDA margin
7.5%
-68% vs 2024
Equity ratio
26.1%
Financial strength
Net profit 2025
DKK 176K
-91% vs 2024
| Revenue | DKK 12,4M | -9% |
| EBITDA | DKK 932K | -68% |
| Net profit | DKK 176K | -91% |
| Total assets | DKK 8,3M | -37% |
| Equity | DKK 2,2M | -50% |
| Employees | 30 | — |
Legal name
Dyrlægegruppen Dania A/S
CVR number
41072164
Legal form
Aktieselskab
NACE code
7500 · Veterinary activities
Founded
28. oktober 2019
Share capital
DKK 400.000
Employees
30 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening, af et medlem af bestyrelsen i forening med et medlem af
direktionen eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive dyrlægepraksis, og dermed beslægtet virksomhed.
Address
Finlandsvej 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 11.970 | 12.094 | 13.146 | 13.630 | 12.369 |
| Staff expenses | -8.918 | -9.807 | -10.549 | -10.689 | -11.437 |
| EBITDA | 3.052 | 2.287 | 2.597 | 2.941 | 932 |
| Depreciation & amort. | -310 | -328 | -321 | -298 | -761 |
| EBIT | 2.742 | 1.959 | 2.276 | 2.643 | 171 |
| Net financials | -121 | -214 | -266 | -266 | 16 |
| Profit before tax | 2.621 | 1.746 | 2.010 | 2.378 | 187 |
| Tax | 570 | 406 | 442 | 523 | 11 |
| Net profit | 2.051 | 1.340 | 1.567 | 1.854 | 176 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 9.645 | 11.140 | 13.776 | 13.171 | 8.289 |
| Equity | 3.825 | 3.565 | 3.933 | 4.287 | 2.163 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5.407 | 7.160 | 9.432 | 8.475 | 5.906 |
| Total debt | 5.407 | 7.160 | 9.432 | 8.475 | 5.906 |
EBITDA margin
7.5%
This company
15.8%
Market median
-53% vs market
20212025
Equity ratio
26.1%
This company
38.2%
Market median
-32% vs market
20212025
Return on equity
8.1%
This company
18.4%
Market median
-56% vs market
20212025
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
20212025
Asset turnover
1.49×
This company
1.12×
Market median
+33% vs market
20212025
Debt / equity
2.83×
This company
0.62×
Market median
-356% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CM Management | Management | 2026 |
| Former (1) | ||
EK Management | Management | 2025 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 | |
| Individual | 33.33–49.99% | 33.33–49.99% | 2019 | |
| Company | 100% | 100% | 2020 | |
| Individual | 33.33–49.99% | 33.33–49.99% | 2019 | |
| Individual | 33.33–49.99% | 33.33–49.99% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EVIDENSIA DYREHOSPITAL A/S
Dyrlægegruppen Dania A/S Board members of Dyrlægegruppen Dania A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl-Magnus Månsson | Management | 0 companies |
| Evelina Karin Ögren | Management | 0 companies |
| Eric Mattias Lundström | Chairman | 0 companies |
| Rune Gottschalck Rehlund | Board of Directors | 0 companies |